Cleveland Clinic Main Campus
Rheumatologic and Immunologic Disease
Solon Family Health Center
29800 Bainbridge Road
Solon, OH 44139
- Administration Of Injectable Medications For Osteoporosis
- Adult Rheumatology
- Arthritic Knee Conditions
- Bone Density Testing
- Clinical Trials
- Cortisone injections
- Diagnosis of Osteoporosis
- Dual Energy X-ray Absorptiometry (DXA)
- General Rheumatology
- General Rheumatology including Lupus
- Hyaluronic acid (HA)
- Hyaluronic acid injections
- Infusion Therapy
- Infusions Of Biologic Agents On Site
- Joint Aspiration
- Joint Injections
- Joint Preservation Center
- Medical Management of Early Osteoarthritis
- Medication Management
- Musculoskeletal Evaluation
- Musculoskeletal Medicine
- Musculoskeletal Treatment For Joint Pain
- Steroid Injections
- Therapeutic Injections
- Ultrasound-guided Procedures
- Viscosupplementation Injections
View all 29 Treatment & Services +
- Ankylosing Spondylitis
- Antiphospholipid Syndrome
- Arthritic Knee Problems
- Arthritis Of The Hip
- Arthritis Of The Knee
- Arthritis of the Thumb Base
- Arthritis of the Wrist & Hand
- Autoimmune Disease
- Autoinflammatory Syndromes
- Benign Hypermobility Joint Syndrome
- Calcification Tendinitis
- Chondrocalcinosis (Pseudo Gout)
- Connective Tissue Diseases
- Connective Tissue Disorders
- Elbow Arthritis
- Familial Mediterranean Fever
- Familial Mediterranean Fever (FMF) Syndrome
- Gout Arthritis
- Hand and Wrist Arthritis
- Hand Pain
- Hand Problems
- Hip Arthritis
- Hip Disorders
- Hip Pain
- Inflammatory Arthritis
- Joint Pain
- Knee Arthritis
- Knee Joint Disorders
- Knee Pain
- Lupus Anticoagulant
- Lupus Nephritis
- Metabolic Bone Disease
- Metabolic Diseases
- Musculoskeletal Disorders
- Musculoskeletal Impairments
- Musculoskeletal Pain
- Osteoarthritis Of The Hips And Knees In The Elderly
- Osteoporosis in Men
- Osteoporosis Related to Cancer
- Paget's Disease
- Painful Joints
- Palindromic Rheumatism
- Psoriatic Arthritis
- Raynaud's Phenomenon
- Reactive Arthritis
- Relapsing Polychondritis
- Retroperitoneal Fibrosis
- Rheumatoid Arthritis
- Rheumatoid Arthritis and Heart Disease
- Rheumatoid Arthritis: How to Treat
- Shoulder Arthritis
- Sjogren's Syndrome
- Steroid-Induced Osteoporosis
- Systemic Autoimmune Diseases
- Systemic Lupus
- Systemic Lupus Erythematosus
- Trigger Finger
- Vitamin D Deficiency
View all 84 Specialties +
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan. View All Plans
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All Plans
- Industry Relationships
About Chad Deal, MD
Chad Deal, MD, is Head of the Center for Osteoporosis and Metabolic Bone Disease and a board-certified Rheumatologist at Cleveland Clinic. He has specialty interests in osteoporosis and related conditions. Dr. Deal did his undergraduate work at Washington University, St. Louis, Mo. He attended medical school at the University of Arkansas, was inducted into Alpha Omega Alpha, and graduated in 1977. His internship and residency were at Boston City Hospital in Boston, Mass. He completed a fellowship in arthritis and connective tissue diseases at Boston University School of Medicine in 1982.
Dr. Deal has been in Cleveland since 1984. He was Associate Professor of Medicine at the Case Western Reserve University School of Medicine until 1999, when he left to become Head of the Center for Osteoporosis and Metabolic Bone Disease at Cleveland Clinic.
Dr. Deal has been an active investigator in multiple clinical trials relating to arthritis and osteoporosis. He has been an investigator in numerous multicenter trials, including drug trials using teriparatide (PTH) with raloxifene, zoledronic acid after teriparatide, and novel anabolic agents. He is author of over 50 publications.
He is a past member on the Committees on Rheumatologic Care, Training and Workforce, and Finance for the American College of Rheumatology. He is currently on the Board of Directors of the American College of Rheumatology. He is a member of the Interspecialty Medical Council of the NOF for the ACR. Dr. Deal is a reviewer for numerous rheumatology, orthopedic and osteoporosis journals. He has received the National Volunteer Service Citation from the Arthritis Foundation, and has been awarded Teacher of the Year in Rheumatic Diseases at Cleveland Clinic. He has been named one of the best doctors in Cleveland.
Learn from Dr. Deal on how osteoporosis, the ‘silent thief of bone,’ can be prevented, detected and treated. Both men and women get osteoporosis and it's a common misconception that only women have osteoporosis.
Hear from other Cleveland Clinic specialists
Education & Professional Highlights
Education & Fellowships
Fellowship - Boston Medical Center
Residency - Boston Medical Center
Internship - Boston Medical Center
Medical Education - University of Arkansas College of Medicine
Little Rock,AR USA
Undergraduate - Washington University
History & Biology
St. Louis,MO USA
- Board of Directors, American College of Rheumatology
- Internal Medicine
- Internal Medicine - Rheumatology
Osteoporosis, metabolic bone disease, steroid osteoporosis, connective tissue disease, Paget’s Disease
Awards & Honors
- Best Doctor, Cleveland magazine
- American College of Rheumatology
- American Society of Bone and Mineral Research
- International Society of Clinical Densitometry
Research & Publications
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/2/2021, Dr. Deal has reported the financial relationships with the companies listed below.In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Deal receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:
- Amgen, Inc.
- Alexion Pharmaceuticals, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
228 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
4.9 out of 5
(Video) Osteoporosis: Causes, Symptoms & Treatment
|Courtesy, Respect & Concern||4.9|
|Patient Rating of Doctor||4.9|
65 Patient Comments
© 2022 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.